Filtros de búsqueda

Lista de obras de

A Systematic Review of the Cost-Effectiveness of Biologics for Ulcerative Colitis

artículo científico publicado en 2017

A comment on Craig et al.: ''Retigabine for the adjunctive treatment of adults with partial-onset seizures in epilepsy with and without secondary generalization: a NICE single technology appraisal''.

artículo científico publicado en 2013

A multi-country health economic evaluation of highly concentrated N-3 polyunsaturated fatty acids in secondary prevention after myocardial infarction

artículo científico publicado en 2006

A multi-country health-economic evaluation of highly concentrated n-3 polyunsaturated fatty acids in the secondary prevention after myocardial infarction

artículo científico publicado en 2006

An indirect comparison of infliximab versus adalimumab or golimumab for active ulcerative colitis

artículo científico publicado en 2016

An indirect comparison of ustekinumab and vedolizumab in the therapy of TNF-failure Crohn's disease patients

artículo científico publicado en 2017

Associations of Nutritional Behavior and Gut Microbiota with the Risk of COVID-19 in Healthy Young Adults in Poland

artículo científico publicado en 2022

Clinical efficacy and safety of prolonged use of the valganciclovir for the treatment of cytomegalovirus disease in patients after kidney transplantation

artículo científico publicado en 2013

Coffee consumption and colorectal cancer risk: a dose-response meta-analysis on prospective cohort studies

scientific article published on 28 March 2019

Comparative Analysis of Legislative Requirements About Patients' Access to Biotechnological Drugs for Rare Diseases in Central and Eastern European Countries

article

Cost-Effectiveness Analysis of 1-Year Treatment with Golimumab/Standard Care and Standard Care Alone for Ulcerative Colitis in Poland

artículo científico publicado en 2016

Cost-Effectiveness Analysis of Crohn's Disease Treatment with Vedolizumab and Ustekinumab After Failure of Tumor Necrosis Factor-α Antagonist.

artículo científico publicado en 2018

Cost-Utility Analysis of Infliximab with Standard Care versus Standard Care Alone for Induction and Maintenance Treatment of Patients with Ulcerative Colitis in Poland

artículo científico publicado en 2016

Cost-effectiveness of a cardiovascular disease primary prevention programme in a primary health care setting. Results of the Polish part of the EUROACTION project

scientific article published on 01 January 2013

Cost-effectiveness of biological treatment of ulcerative colitis - a systematic review

artículo científico publicado en 2017

Cost-utility analysis of 1-year treatment with adalimumab/standard care and standard care alone for ulcerative colitis in Poland

artículo científico publicado en 2016

Cost-utility analysis of Ruconest(®) (conestat alfa) compared to Berinert(®) P (human C1 esterase inhibitor) in the treatment of acute, life-threatening angioedema attacks in patients with hereditary angioedema

artículo científico publicado en 2013

Cultural adaptation of the Safety Attitudes Questionnaire - Short Form (SAQ-SF) in Poland

artículo científico publicado en 2021

Developments in the discovery and design of intranasal antidepressants

scientific article published on 21 June 2020

Disease activity, quality of life and indirect costs of psoriatic arthritis in Poland.

artículo científico publicado en 2016

Disease activity, quality of life and indirect costs of reduced productivity at work, generated by Polish patients with ankylosing spondylitis

artículo científico publicado en 2015

Disease activity, quality of life, and indirect costs of ulcerative colitis in Poland

artículo científico publicado en 2017

Drug Policies in Central and Eastern European Countries

artículo científico publicado en 2017

Drug Policy in Bulgaria.

artículo científico publicado en 2017

Drug Policy in Poland

artículo científico publicado en 2017

Economic evaluation of single-pill combination of indapamide and amlodipine in the treatment of arterial hypertension in the Polish setting.

artículo científico publicado en 2015

Economic evaluation of sipuleucel-T immunotherapy in castration-resistant prostate cancer.

artículo científico

Efavirenz-Based Regimens in Antiretroviral-Naive HIV-Infected Patients: A Systematic Review and Meta-Analysis of Randomized Controlled Trials

artículo científico publicado en 2015

Effectiveness and safety of vedolizumab for treatment of Crohn's disease: a systematic review and meta-analysis

artículo científico publicado en 2016

Effectiveness of fixed-dose combination therapy in hypertension: systematic review and meta-analysis

article

Effectiveness of targeted therapy as monotherapy or combined therapy in patients with relapsed or refractory multiple myeloma: a systematic review and meta-analysis

artículo científico publicado en 2014

Effectiveness of targeted therapy in patients with previously untreated metastatic breast cancer: a systematic review and meta-analysis

artículo científico publicado en 2014

Efficacy and safety of intranasal esketamine for the treatment of major depressive disorder

scientific article published on 30 October 2019

Efficacy and safety of ustekinumab in the induction therapy of TNF-α-refractory Crohn's disease patients: a systematic review and meta-analysis

artículo científico publicado en 2017

Efficacy of single and repeated administration of ketamine in unipolar and bipolar depression: a meta-analysis of randomized clinical trials

scientific article published on 16 April 2020

European perspective on the management of rheumatoid arthritis: clinical utility of tofacitinib

artículo científico publicado en 2017

Health technology assessment and reimbursement policy for oncology orphan drugs in Central and Eastern Europe

artículo científico publicado en 2020

Health technology assessment of medical devices

artículo científico publicado en 2018

Health utility of patients with Crohn's disease and ulcerative colitis: a systematic review and meta-analysis

artículo científico publicado en 2016

Health-Related Quality of Life Impairment and Indirect Cost of Crohn's Disease: A Self-Report Study in Poland

artículo científico publicado en 2016

Impact of Biologic Treatment of Crohn's Disease on the Rate of Surgeries and Other Healthcare Resources: An Analysis of a Nationwide Database From Poland.

artículo científico publicado en 2018

Impact of patient outcomes and cost aspects on reimbursement recommendations in Poland in 2012-2014.

artículo científico publicado en 2016

Implementation of the 2011 Reimbursement Act in Poland: Desired and undesired effects of the changes in reimbursement policy.

artículo científico publicado en 2016

Indirect costs of inflammatory bowel diseases: Crohn's disease and ulcerative colitis. A systematic review

artículo científico publicado en 2016

Indirect health costs in ulcerative colitis and Crohn's disease: a systematic review and meta-analysis.

artículo científico

Lenvatinib for the treatment of radioiodine-refractory differentiated thyroid carcinoma: a systematic review and indirect comparison with sorafenib.

artículo científico publicado en 2016

Nevirapine-based regimens in HIV-infected antiretroviral-naive patients: systematic review and meta-analysis of randomized controlled trials

artículo científico publicado en 2013

New alternative in the treatment of rheumatoid arthritis: clinical utility of baricitinib

artículo científico publicado en 2019

Nutrition Behaviors in Polish Adults before and during COVID-19 Lockdown

artículo científico publicado en 2020

Pharmaceutical Regulation in Central and Eastern European Countries: A Current Review.

artículo científico publicado en 2017

Pharmaceutical regulation in 15 European countries review

artículo científico publicado en 2016

Potential Cost-Savings From the Use of the Biosimilars in Slovakia

scientific article published on 21 August 2020

Pregabalin for the treatment of social anxiety disorder

artículo científico publicado en 2014

Prevalence and drug treatment practices of inflammatory bowel diseases in Poland in the years 2012-2014: an analysis of nationwide databases.

artículo científico publicado en 2017

Pricing and Reimbursement of Biosimilars in Central and Eastern European Countries

artículo científico publicado en 2017

Productivity Loss Among Parents of Children with Inflammatory Bowel Diseases in Relation to Disease Activity and Patient's Quality of Life

artículo científico publicado en 2020

Pseudomeningeal syndrome of Dupre associated with cervical discopathy--case report

artículo científico publicado en 2009

Quality of life related to oral, subcutaneous, and intravenous biologic treatment of inflammatory bowel disease: a time trade-off study

artículo científico publicado en 2017

Reimbursement Legislations and Decision Making for Orphan Drugs in Central and Eastern European Countries

artículo científico publicado en 2019

Reimbursement Status and Recommendations Related to Orphan Drugs in European Countries

scientific article published on 27 November 2019

Reimbursement of Orphan Drugs in Europe in Relation to the Type of Authorization by the European Medicines Agency and the Decision Making Based on Health Technology Assessment

article

Relating Health Technology Assessment recommendations and reimbursement decisions in Poland in years 2012-2014, a retrospective analysis.

artículo científico publicado en 2016

Relationship between physician-based assessment of disease activity, quality of life, and costs of ulcerative colitis in Poland.

artículo científico publicado en 2018

Safety Profile of Biologic Drugs in the Therapy of Ulcerative Colitis: A Systematic Review and Network Meta-Analysis

artículo científico publicado en 2016

Safety Profile of Biologic Drugs in the Treatment of Inflammatory Bowel Diseases: A Systematic Review and Network Meta-analysis of Randomized Controlled Trials.

artículo científico publicado en 2016

Safety profile of biologic drugs in the therapy of Crohn disease: A systematic review and network meta-analysis

artículo científico publicado en 2016

Sipuleucel-T immunotherapy for castration-resistant prostate cancer. A systematic review and meta-analysis

artículo científico publicado en 2012

Systematic review of the effectiveness of biological therapy for active moderate to severe ulcerative colitis

artículo científico publicado en 2014

The European challenges of funding orphan medicinal products

artículo científico publicado en 2018

The correlation between HTA recommendations and reimbursement status of orphan drugs in Europe

scientific article published on 06 September 2016

The effectiveness of dimethyl fumarate monotherapy in the treatment of relapsing-remitting multiple sclerosis: a systematic review and meta-analysis

artículo científico publicado en 2014

The effectiveness of tofacitinib, a novel Janus kinase inhibitor, in the treatment of rheumatoid arthritis: a systematic review and meta-analysis

artículo científico publicado en 2013

The impact of implemented regulations on biosimilars in Slovakia

artículo científico publicado en 2019

The indirect costs of ankylosing spondylitis: a systematic review and meta-analysis

artículo científico

The indirect costs of multiple sclerosis: systematic review and meta-analysis

artículo científico

The indirect costs of psoriatic arthritis: systematic review and meta-analysis

artículo científico

The safety of dipeptidyl peptidase-4 (DPP-4) inhibitors or sodium-glucose cotransporter 2 (SGLT-2) inhibitors added to metformin background therapy in patients with type 2 diabetes mellitus: a systematic review and meta-analysis

artículo científico publicado en 2014

Trends and determinants in reimbursement decision-making in Poland in the years 2013-2015.

artículo científico publicado en 2017

Tumor necrosis factor-α antibodies (infliximab, adalimumab and certolizumab) in Crohn's disease: systematic review and meta-analysis

artículo científico publicado en 2013

Vedolizumab Compared with Certolizumab in the Therapy of Crohn Disease: A Systematic Review and Indirect Comparison

artículo científico publicado en 2016

[Administration of conestat alfa, human C1 esterase inhibitor and icatibant in the treatment of acute angioedema attacks in adults with hereditary angioedema due to C1 esterase inhibitor deficiency. Treatment comparison based on systematic review re

artículo científico publicado el 1 de enero de 2013

[The evaluation of cost-effectiveness and cost-utility of valganciclovir for the prophylaxis of cytomegalovirus disease to 200 days after kidney transplantation]

artículo científico publicado en 2013

Dominio Público Uruguay está sostenido por:

Acerca de Dominio Público Uruguay

Ayuda